Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

Maddalena Barba,Li Yang,Holger J. Schünemann,Francesca Sperati,Sara Grioni,Saverio Stranges,Kim C. Westerlind,Giovanni Blandino,Michele Gallucci,Rossella Lauria,Luca Malorni,Paola Muti

Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

2009

Maddalena Barba
Li Yang
Holger J. Schünemann
Francesca Sperati
Sara Grioni
Saverio Stranges
Kim C. Westerlind
Giovanni Blandino
Michele Gallucci
Rossella Lauria
Luca Malorni
Paola Muti

Objective To investigate prostate cancer (Pca) risk in relation to estrogen metabolism, expressed as urinary 2-hydroxyestrone (2-OHE1), 16α-hydroxyestrone (16α-OHE1) and 2-OHE1 to 16α-OHE1 ratio.

Keywords:

Prostate-specific antigen
Odds ratio
Prostate cancer
Estrogen
Case-control study
Body mass index
Internal medicine
Oncology
Urinary system
Medicine
PCA3
Logistic regression
Meta-analysis
Cohort study
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations